Physician profile
Bryon S Bigham
NPI 1518053594
$1,335.41
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $240 · 2021: $455 · 2022: $355.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $236.34 | 2019-2022 | |
| Amgen INC. | $167.77 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $125.15 | 2019-2022 | |
| Abbvie INC. | $114.85 | 2021-2022 | |
| Lilly USA, LLC | $112.75 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.00 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.60 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $76.68 | 2019-2021 | |
| Novo Nordisk INC | $68.17 | 2020-2022 | |
| Sanofi Pasteur INC. | $31.34 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.80 | 2022 | |
| Genzyme Corporation | $28.42 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $26.73 | 2019 | |
| Amarin Pharma, INC. | $22.99 | 2020 | |
| Roche Diagnostics Corporation | $17.03 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $15.43 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.90 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.60 | 2019 | |
| Astellas Pharma US INC | $13.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.00 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $12.17 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryon Bigham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.